Sub-study of the Essen Study Centre for the ENTAiER Trial

NCT ID: NCT04532073

Last Updated: 2023-12-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-07-27

Study Completion Date

2022-12-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The present study is a sub-study of the ENTAiER study. The ENTAiER study is a multicenter, randomized, controlled study to evaluate the efficacy and safety of eurythmy therapy and Tai Chi in comparison to standard care in chronically ill older patients with an increased risk of falling.

In addition to the main questions of the ENTAiER study, three additional questions are being investigated at the Hospital Essen-Steele: Proteome and telomere analyses as well as qualitative parameters are recorded and examined. The aim is to compare the changes in proteomes, telomeres and qualitative factors under eurythmy therapy, Tai Chi and standard care in chronically ill older patients with an increased risk of falling.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Elderly Patients Chronically Ill Increased Risk of Falling

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Eurythmy therapy exercises

As part of the ENTAiER trial: In group sessions á 5 patients with a qualified therapist: In the first 3 months twice a week, in the second 3 months once a week. Recommendation to practice at home on at least 3 days per week (optimal, practice daily). They are supported by an eurythmy manual and an exercise video. This supplements the regular care.

Group Type EXPERIMENTAL

Eurythmy Therapy

Intervention Type OTHER

A mindfulness-oriented movement therapy

Tai Chi exercises

As part of the ENTAiER trial:In group sessions of 5 patients each with a qualified teacher: In the first 3 months twice a week, in the second 3 months once a week. Recommendation to practice at home on at least 3 days per week (optimal, practice daily). They are supported by a Tai Chi Manual and an exercise video. This complements the regular care

Group Type EXPERIMENTAL

Tai Chi

Intervention Type OTHER

A martial art developed in China, which in recent times is often regarded as a system of movement theory or gymnastics

Standard Care Only

As part of the ENTAiER trial:Brochure with detailed description of various evidence-based measures for fall prevention, prepared for the specific age group (https://www.trittsicher.org/files/trittsicher\_bzga\_sturzpraevention\_2015-11-23.pdf)

\- Recommendation to visit the family doctor and discuss fall prophylaxis with her

Group Type ACTIVE_COMPARATOR

Standard Care

Intervention Type OTHER

Treatment process that a clinician should follow for a certain type of patient

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Eurythmy Therapy

A mindfulness-oriented movement therapy

Intervention Type OTHER

Tai Chi

A martial art developed in China, which in recent times is often regarded as a system of movement theory or gymnastics

Intervention Type OTHER

Standard Care

Treatment process that a clinician should follow for a certain type of patient

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* At least 65 years.
* Chronic disease (musculoskeletal, neurological, internal medicine).
* Increased risk of falling (Berg Balance Scale Score 49 or less).
* Medical history: feeling of balance disturbance in the past.
* Independent living at home or in an old people's or retirement home.
* Regular participation in a one-hour event is possible.
* Sufficiently mobile to leave the place of residence independently at least twice a week
* Written declaration of consent.

Exclusion Criteria

* Disease that restricts participation (e.g. terminal disease, heart failure NYHA III-IV, unstable angina pectoris, uncontrolled seizure disorder, decompensated lung disease that already leads to shortness of breath during light activity, advanced cancer, chemo- or radiotherapy ongoing or during the last 3 months, amputation of one or both legs)
* Complete dependence on the rollator.
* Visual, hearing or speech problems that limit the understanding of the study documents and processes.
* Major cognitive impairment (MoCA score 18 or less).
* High risk of needing individual supervision during group sessions.
* Severe personality disorder or psychiatric illness, alcoholism or other substance dependence affecting the group sessions.
* Life expectancy under 1 year.
* Permanent bed-riddenness expected in less than one year.
* Regular participation in Tai Chi or EYT in the last 6 months.
* Participation in intensive sports activities in the last month (e.g. training in the fitness centre or in sports groups which lead to breathlessness and sweating; skiing, mountaineering in high mountains).
* Patients who cannot understand the nature, meaning and necessities of participating in a study.
* Participation in another clinical trial within 3 months prior to screening for the ENTAiER trial or concurrent participation in another trial that may interfere with this trial.
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Software AG Stiftung

UNKNOWN

Sponsor Role collaborator

Universität Freiburg

UNKNOWN

Sponsor Role collaborator

Universität Duisburg-Essen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Holger Cramer

Research Director

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kliniken Essen-Mitte

Essen, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20-9421-BO

Identifier Type: -

Identifier Source: org_study_id